Nateglinide and angina pectoris Patient Reports February 11, 2012

Nateglinide Side Effects Report #4874983-X
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 28, 2005. Female patient, 76 years of age, weighting 216.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, bronchitis chronic, cholecystitis chronic, coronary artery disease , disease progression, dizziness , dyspnoea, hypertension. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, CARDIKET, VERAPAMIL, HYPOTHIAZID, MONO MACK. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5475414-1
Nateglinide side effect was reported by a Physician from MALAYSIA on Sept 20, 2007. Male patient, 67 years of age, weighting 174.2 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, chest discomfort, diarrhoea, gouty arthritis, reflux oesophagitis. Nateglinide dosage: 60 MG, UNK. During the same period patient was treated with VALSARTAN, TICLID, PLAVIX, BETALOC, LOVASTATIN, VASTAREL, ISORDIL, ISOSORBIDE MONONITRATE. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5483274-8
Nateglinide side effect was reported by a Physician from MALAYSIA on Oct 03, 2007. Male patient, 67 years of age, weighting 174.2 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, chest discomfort, diarrhoea, gouty arthritis, reflux oesophagitis. Nateglinide dosage: 60 MG, UNK. During the same period patient was treated with VALSARTAN, TICLID, PLAVIX, BETALOC, LOVASTATIN, VASTAREL, ISORDIL, ISOSORBIDE MONONITRATE. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5327767-2
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on May 10, 2007. Female patient, 59 years of age, weighting 217.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, autoimmune thyroiditis, blood cholesterol increased, cardiac failure, chest pain , coronary artery disease , dyspnoea, hepatic steatosis, high density lipoprotein decreased. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.


Nateglinide Side Effects Report #5332447-3
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on May 17, 2007. Female patient, 59 years of age, weighting 217.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, autoimmune thyroiditis, blood cholesterol increased, cardiac failure, chest pain , coronary artery disease , dyspnoea, hepatic steatosis, high density lipoprotein decreased. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5662498-0
Nateglinide side effect was reported by a Physician from UNITED STATES on Mar 04, 2008. Female patient, 53 years of age, weighting 280.0 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: acute coronary syndrome, acute myocardial infarction, angina pectoris, angina unstable, arterial haemorrhage, chest pain , coronary angioplasty, coronary arterial stent insertion, coronary artery disease . Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.